Related Experiment Video
Updated: Jul 4, 2026
05:28
A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
Raptor therapeutics
1PAWS Wildlife Center, Lynnwood, Washington, USA.
Summary
Developing effective therapeutic plans for raptors requires careful consideration of their unique medical and natural history needs. This guide offers essential guidelines for managing raptor patients and treating common conditions in captivity.
Area of Science:
- Veterinary Medicine
- Wildlife Conservation
- Avian Biology
Background:
- Therapeutic plan development for raptors presents unique challenges due to complex patient factors.
- Successful raptor treatment hinges on comprehensive management from initial presentation through captivity.
Purpose of the Study:
- To address key medical and natural history considerations specific to raptors.
- To provide guidelines for creating effective therapeutic plans for wild raptors.
Main Methods:
- Review of medical and natural history factors pertinent to raptor care.
- Synthesis of information to formulate treatment strategies for common raptor diseases.
Main Results:
- Identification of critical factors influencing raptor therapeutic plan development.
- Presentation of practical guidelines for managing and treating common raptor ailments.
Conclusions:
- Effective raptor therapy necessitates a holistic approach integrating medicine and natural history.
- The presented guidelines aim to improve patient outcomes for wild raptors under veterinary care.
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:26Receptor Tyrosine Kinases
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:28Rabies
Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...